BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...

Preventive health care encompasses a host of strategies designed to reduce individuals’ risk for conditions and diseases that can adversely affect their quality of life. Routine exercise and a ...

In preclinical prostate cancer models, HLD-0915 treatment resulted in tumor shrinkage and declines in prostate-specific antigen. The Food and Drug Administration (FDA) has granted Fast Track ...

The Food and Drug Administration has granted a Fast Track designation to the novel immune activator drug BXCL701 in combination with a checkpoint inhibitor for patients with metastatic small cell ...

(WXYZ) — In today's health alert, the second leading cause of cancer-related deaths among men worldwide may soon have a promising new treatment. Biontech has ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced several regulatory actions. Here is an overview of decisions that may be relevant to your ...

Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published Aug ...